MedTrace Logo

Effects of Psychiatric Admissions on Self-harm and Suicide in People With Borderline Personality Disorder

NCT06424509 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 390

Last updated 2025-08-12

No results posted yet for this study

Summary

The current study aims to evaluate the impact of long (\>5 days) and/or compulsory psychiatric inpatient care on subsequent healthcare utilization for self-harm and suicide in people with borderline personality disorder, a condition characterized by frequent self-harm.

The basis for this study is the diversity of clinical practices across Swedish regions. By categorizing clinics based on their practices with respect to long and/or compulsory psychiatric inpatient care, it is possible to explore the impact of these practices on subsequent somatic and psychiatric healthcare, including emergency care due to self-harm as well as on completed suicides.

All psychiatric clinics across Sweden authorized to administer compulsory care for adults, totalling 78 clinics will be included. Each clinic per specific calendar year will represent one participant, identified by the clinic's name and the respective year (e.g., Umeå2010, Linköping2013, Malmö2022).

Data collection will involve the utilization of the national registers to capture outcome measures and account for confounding factors. The participants will be ranked based on a composite variable, which includes the average number of days spent in inpatient compulsory care and other psychiatric inpatient care exceeding 5 days, among individuals diagnosed with BPD. The top quartile of participants will be compared with the bottom quartile.

Conditions

  • Borderline Personality Disorder
  • Self-harm
  • Non-suicidal Self-injury
  • Suicide

Interventions

OTHER

High degree of long (>5 days) and/or compulsory psychiatric inpatient care

High degree of long (\>5 days) and/or compulsory psychiatric inpatient care

Sponsors & Collaborators

  • Linkoeping University

    collaborator OTHER_GOV

  • Lund University

    lead OTHER

Principal Investigators

  • Sofie Westling, MD, PhD · Lund University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2026-01-01
Completion
2027-01-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06424509 on ClinicalTrials.gov